National Institutes of Health
Improved Drug Susceptibility Testing (DST) for Mycobacteria
Improved Drug Susceptibility Testing (DST) for Mycobacteria is a funding opportunity from National Institutes of Health. Its application deadline is not stated in the source record.
We could not verify this deadline.
This listing carries no application deadline we can confirm, so it may no longer be open. Check the official solicitation before investing time, and create a free account to see opportunities we can verify are live.
Overview
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting research to develop improved drug susceptibility tests (DSTs) for mycobacterial drugs, including those currently used for treatment of tuberculosis (TB) and clinically important non-tuberculous mycobacterial…